Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltdverified

CU6.AX

Price:

$3.155

Market Cap:

$1.17B

Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company has...[Read more]

Industry

Biotechnology

IPO Date

2021-08-25

Stock Exchange

ASX

Ticker

CU6.AX

The Enterprise Value as of December 2025 (TTM) for Clarity Pharmaceuticals Ltd (CU6.AX) is 1.13B

According to Clarity Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 1.13B. This represents a change of 14.11% compared to the average of 986.86M of the last 4 quarters.

Clarity Pharmaceuticals Ltd (CU6.AX) Historical Enterprise Value (quarterly & annually)

How has CU6.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Clarity Pharmaceuticals Ltd over the last ten years is 481.28M. The current 1.13B Enterprise Value has changed 23.30% with respect to the historical average. Over the past ten years (40 quarters), CU6.AX's Enterprise Value was at its highest in in the June 2024 quarter at 1.41B. The Enterprise Value was at its lowest in in the December 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

481.28M

Median

380.81M

Minimum

70.99M

Maximum

1.36B

Clarity Pharmaceuticals Ltd (CU6.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Clarity Pharmaceuticals Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 801.03%

Maximum Annual Enterprise Value = 1.36B

Minimum Annual Increase = -81.17%

Minimum Annual Enterprise Value = 70.99M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025750.32M-44.67%
20241.36B801.03%
2023150.51M112.02%
202270.99M-81.17%
2021376.95M-0.83%
2020380.13M-0.36%
2019381.50M-0.58%

Clarity Pharmaceuticals Ltd (CU6.AX) Average Enterprise Value

How has CU6.AX Enterprise Value performed in the past?

The current Enterprise Value of Clarity Pharmaceuticals Ltd (CU6.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

752.32M

5-year avg

540.98M

10-year avg

481.28M

Clarity Pharmaceuticals Ltd (CU6.AX) Enterprise Value vs. Peers

How is CU6.AX’s Enterprise Value compared to its peers?

Clarity Pharmaceuticals Ltd’s Enterprise Value is less than Neuren Pharmaceuticals Limited (2.42B), greater than PYC Therapeutics Limited (708.28M), greater than Dimerix Limited (269.24M), less than Mesoblast Limited (2.50B), less than Regis Healthcare Limited (2.09B), greater than Orthocell Limited (233.69M), greater than Immutep Limited (437.61M), greater than Nanosonics Limited (1.12B), greater than Island Pharmaceuticals Limited (107.78M), greater than Clinuvel Pharmaceuticals Limited (424.53M),

Build a custom stock screener for Clarity Pharmaceuticals Ltd (CU6.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarity Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clarity Pharmaceuticals Ltd (CU6.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clarity Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Clarity Pharmaceuticals Ltd's Enterprise Value?

What is the highest Enterprise Value for Clarity Pharmaceuticals Ltd (CU6.AX)?

What is the 3-year average Enterprise Value for Clarity Pharmaceuticals Ltd (CU6.AX)?

What is the 5-year average Enterprise Value for Clarity Pharmaceuticals Ltd (CU6.AX)?

How does the current Enterprise Value for Clarity Pharmaceuticals Ltd (CU6.AX) compare to its historical average?